Initially extracted from bovine or pig pancreas, Insulins used nowadays are more and more of the "recombinant" type; produced by recombinant DNA technology, utilizing E. coli or yeast (Saccharomyces) fermentation.
On January 26, 2006, FDA approved for the first time a human insulin inhalation powder, this one being a non modified insulin.